Page results
-
The Com-Cov trial in which UCLH is a site looking at alternating vaccines has been expanded to include the Moderna and Novavax vaccines.
-
Over 150 people visited a highly successful health and research engagement event in Camden which engaged the local community in healthcare innovation, research, and how to stay healthy.
-
The team behind the Royal National ENT and Eastman Dental Hospitals won the Estates Initiative of the Year at the HSJ Value Awards 2020.
-
UCLH Biomedical Research Centre supported Consultant Infectious Diseases Physician Professor Sir Alimuddin (Ali) Zumla has been awarded the 2020 Mahathir Science Award, the most prestigious international science award presented in recognition for the best scientific work in solving priority health problems in the tropics.
-
A team at UCLH, UCL and Mercedes-AMG High Performance Powertrains which developed a Continuous Positive Airway Pressure (CPAP) breathing aid now used in hospitals across the UK have received an award from the Royal Academy of Engineering for exceptional services during a pandemic.
-
The court has granted permission to appeal a High Court ruling relating to puberty-blocking treatment in cases of gender dysphoria.
-
How we use your information at UCLH: what you need to know
-
As part of Our National Health Stories, University College London Hospitals NHS Foundation Trust commissioned five poets to write and share stories from the NHS.
-
Whilst the UCLH paediatric emergency department remains on divert, access for GPs to paediatrics remains available as usual.
-
We are asking patients to follow some protocols before they come to UCLH and would appreciate it if you could reiterate this with your patients when you refer them.
File results
-
FOI/2022/0433 - A&E attendances with effects of heat, light and sunburn
-
FOI/2022/0437 - IT infrastructure systems used at Trust
-
FOI/2022/0443 - Trust spend on lost, stolen or damaged patient property
-
FOI/2022/0448 - Electronic cloud based job evaluation system
-
FOI/2022/0449 - Use of defibrotide for the treatment of Hepatic Veno-occlusive disease
-
FOI/2022/0451 - Patient information leaflets
-
FOI/2022/0454 - Temporary staff waiting list initiative and overtime spend
-
FOI/2022/0456 - Treatment of renal cell carcinoma
-
FOI/2022/0459 - Interpreters and translation services
-
FOI/2022/0465 - Treatment of dermatological conditions